smartbax

This biotech startup develops a new generation of small-molecule antibiotics designed to overcome antimicrobial resistance. The company targets hydrolytic processes and novel protein targets outside of classical pathways to eliminate multi-drug resistant bacteria. Its primary focus is addressing global health threats by designing drugs that outsmart bacterial resistance mechanisms.